Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 28

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 28
---
 our company. Although we have
no present intention to issue any shares of our authorized preferred stock, there can be no assurance that we will not do so in the future.

Provisions in our Articles of Incorporation, our Bylaws, and Nevada law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our Common Stock.

Provisions of our Articles of Incorporation, our
Bylaws, and Nevada law may have the effect of deterring unsolicited takeovers or delaying or preventing a change in control of our company
or changes in our management, including transactions in which our stockholders might otherwise receive a premium for their shares over
then current market prices. In addition, these provisions may limit the ability of stockholders to approve transactions that they may
deem to be in their best interests. These provisions include:

| · | the inability of stockholders to call special meetings; |

| · | the “business combinations” and “control share acquisitions” provisions of Nevada                                                           
 law, to the extent applicable, could discourage attempts to acquire our stockholders stock even on terms above the prevailing market price; 
 and                                                                                                                                         |

| · | the ability of our board of directors to designate the terms of and issue new series of preferred stock                                
 without stockholder approval, which could include the right to approve an acquisition or other change in our control or could be used  
 to institute a rights plan, also known as a poison pill, that would dilute the stock ownership of a potential hostile acquirer, likely 
 preventing acquisitions that have not been approved by our board of directors.                                                         |

The existence of the forgoing provisions and anti-takeover
measures could limit the price that investors might be willing to pay in the future for shares of our Common Stock. They could also deter
potential acquirers of our company, thereby reducing the likelihood that you could receive a premium for your Common Stock in an acquisition.

<div align='center'>15

Cautionary Note
Regarding Forward-Looking Statements</div>

This prospectus and the documents incorporated
by reference into this prospectus contain “forward-looking statements” within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that relate to future events or our future
financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results